The Impact of Libyan Pediatric Atopic Dermatitis on Their Families

Narges Ibrahim Shoaib

Department of Dermatology, Faculty of Medicine, Benghazi University, Benghazi, Libya.

Gamal Ahmed Duweb *

Department of Dermatology, Faculty of Medicine, Benghazi University, Benghazi, Libya.

*Author to whom correspondence should be addressed.


Abstract

Background: Atopic dermatitis (AD) and psoriasis are common chronic skin diseases affecting children. These disorders negatively impact the quality of life (QoL) of patients in health related aspects such as physical, psychosocial, and mental functioning. This health impact is more accurately represented when accounting for the numerous co-morbidities associated with each disorder.

Aim of the Study: To assess the impact of atopic dermatitis on families of children under four years with the condition and to identify factors affecting family impact, in addition to correlate the impact with their quality of life.

Materials and Methods: A cross sectional survey conducted over period of 6 months. The study include 100 families of children aged 4 years and below, with the diagnosis of atopic dermatitis attending outpatients dermatology clinic at Benghazi medical center and AL-Kish polyclinic, Benghazi-Libya. Demographic and clinical data were collected directly using interview data collection form. Three Item Severity (TIS) score included in the study and based on oedema/ papulation, excoriation and erythema. The total score ranged from 0 to 9. To assess the impact of the children's AD on the parents' QoL, the Dermatitis Family Impact Questionnaire was used with score ranges from 0-30, higher score indicated bad quality of life. Data obtained were analyzed using SPSS version 26 at statistical significance 0.05.

Results: In this study 100 families of AD children, 50% males, age ranges from 4 to 47 months, 67% had family history of atopy, 47% suffered from other types of atopies. The mean severity index was 4.58. The FDQLI score was ranged from 0 to 26 (mean 16.64) reflecting moderate family impact. AD impact varies among families, to be moderate in 53%, severe in 31, small in 11% and normal in 5%. Ten areas where AD impact the families quality of life were evaluated. Extra expenditure, people reactions, burden of care, people reaction and emotional impact were the most factors showing the greatest impact caused by the presence of AD child in the family. A correlation between FDLQI and disease severity showed that quality of life was significantly more disturbed with increasing severity of the disease. There were no significant differences in families quality of life score regarding the gender and the age of the child, The quality of life showed a significant association with family’s educational level. Families with education beyond secondary (fathers and mothers) more severely affected.

Conclusion: AD appeared to have a moderate impact on the QoL of the enrolled families. QoL measured by FDLQI was significantly more disturbed with increasing severity of the disease. The quality of life showed a significant negative association with family’s educational level. To the best of our knowledge this is the first to be reported from Libya and North Africa.

Keywords: Atopic dermatitis, children, family impact, FDQLI, Libya


How to Cite

Shoaib, N. I., & Duweb, G. A. (2023). The Impact of Libyan Pediatric Atopic Dermatitis on Their Families. Asian Journal of Research in Dermatological Science, 6(1), 13–21. Retrieved from https://journalajrdes.com/index.php/AJRDES/article/view/80

Downloads

Download data is not yet available.

References

Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1.Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338-351.

Maliyar K, Sibbald C, Pope E, Gary Sibbald R. Diagnosis and management of atopic dermatitis: A review. Adv Skin Wound Care. 2018;31(12):538-550.

Asher MI, Montefort S, Björkstén B, at al. Phase three study group. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368(9537): 733-743.

Weston WL, Lane AT. Color textbook of pediatric dermatology. St Louis: Mosby-Yearbook; 1991.

Rycroft RJG, Robertson SJ, Wakelin SH. Dermatology: A colour handbook, 2nd ed. Manson Publishing, London; 2010.

Katayama I, Aihara M, Ohya Y, et al. Japanese Society of Allergology. Japanese guidelines for atopic dermatitis 2017. Allergol Int. 2017;66(2):230-247.

Schneider L, Tilles S, Lio P, et al. Atopic dermatitis: A practice parameter update 2012. J Allergy Clin Immunol. 2013;131(2): 295-9.

Simpson EL, Bieber T, Eckert L, et al. Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults. J Am Acad Dermatol. 2016;74(3): 491-498.

Drucker AM, Wang AR, Li WQ, et al. The burden of atopic dermatitis: Summary of a report for the National Eczema Association. J Invest Dermatol. 2017;137 (1):26-30.

Chamlin SL, Frieden IJ, Williams et al. Effects of atopic dermatitis on young American children and their families. Pediatrics. 2004;114(3):607-611.

Lawson V, Lewis-Jones MS, Finlay AY, et al. The family impact of childhood atopic dermatitis: The dermatitis family impact questionnaire. Br J Dermatol. 1998;138(1): 107-113.

Basra MK, Sue-Ho R, Finlay AY. The family dermatology life quality index: Measuring the secondary impact of skin disease. Br J Dermatol. 2007;156(3):528-538.

Marciniak J, Reich A, Szepietowski J. The family dermatology life quality index. Forum Dermatol. 2016;2:24–28.

Lee, SI. Common allergic diseases in children. Journal of the Korean Medical Association. 2003;46(3):231-243.

Murray CJ, Vos T, Lozano R, et al., Disability Adjusted Life Years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: A systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2197–2223.

Soo Ick Cho, Jin Hye Kim, Bo Young Chung, et al. Quality of life in children and adolescents with atopic .Dermatitis Korean J Dermatol. 2011;49(5):415-42.

Wolkerstorfer A, de Waard van der Spek FB, Glazenburg EJ, et al. Scoring the severity of atopic dermatitis: Three item severity score as a rough system for daily practice and as a pre-screening tool for studies. Acta Derm Venereol. 1999;79(5): 356-359.

Oranje AP, Glazenburg EJ, Wolkerstorfer A, et al. Practical issues on interpretation of scoring atopic dermatitis: The SCORAD index, objective SCORAD and the three item severity score. Br J Dermatol. 2007; 157(4):645-648.

Finlay AY. Skin disease disability: Measuring its magnitude. Keio J Med. 1998;47:131–4.

Basra MK, Salek MS, Camilleri L, et al. Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): Further data. Dermatology 2015; 230:27–33.

Jang HJ, Hwang S, Ahn Y, et al. Family quality of life among families of children with atopic dermatitis. Asia Pac Alergy. 2016;6:213–219.

Djurović MR, Janković J, Ćirković A, et al. Quality of life in infants with atopic dermatitis and their families. Postepy Dermatol Alergol. 2020;37(1):66-72.

Pustišek N, Šitum M, Vurnek Živković M, et al. The significance of structured parental educational intervention on childhood atopic dermatitis: A randomized controlled trial. J Eur Acad Dermatol Venereol. 2016;30:806–12.

Al Shobaili HA. The impact of childhood atopic dermatitis on the patients’ family. Pediatr Dermatol. 2010;27:618-623.

Kiebert G, Soresen SV, Revicki D, et al. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol. 2002;41:151-158.

Ben-Gashir MA, Seed PT, Hay RJ. Quality of life and disease severity are correlated in children with atopic dermatitis. Br J Dermatol. 2004;150(Suppl. 2):284-290.

Mozaffari H, Pourpak Z, Pourseyed S, et al. Quality of life in atopic dermatitis patients. J Microbiol Immunol and Infect. 2007;40(Suppl. 3):260-264.

Siafaka P, Ipekci E, Caglar EŞ, et al. Current status of pediatric formulations for chronic and acute children' diseases: Applications and future perspectives. Medeni Med J. 2021;36(2):152-162.

Marciniak J, Reich A, Szepietowski JC. Quality of life of parents of children with atopic dermatitis. Acta Derm Venereol. 2017;97(6):711-714.

Ali F, Vyas J, Finlay AY. Counting the burden: Atopic dermatitis and health-related quality of life. Acta Derm Venereol. 2020;100(12):adv00161

Yang EJ, Beck KM, Sekhon S, Bhutani T, Koo J. The impact of pediatric atopic dermatitis on families: A review. Pediatr Dermatol. 2019;36(1):66-71.

Campos ALB, Araújo FM, Santos MALD, et al. Impact of atopic dermatitis on the quality of life of pediatric patients and their guardians. Rev Paul Pediatr. 2017;35: 5–10.